Lucis raises $20M series a
Lucis raised $20M in series a funding, announced on 26 May 2026, led by Singular, with participation from General Catalyst, Y Combinator. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
AI-driven preventive healthcare platform combining biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect health risks earlier. Lucis is based in France and currently at series a stage, operating in healthtech, deeptech.
This funding event is a citable node in Fusion42's market graph: it links Lucis's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur, Fusion42's AI co-founder, reasons over when benchmarking a founder's own raise against what is closing in the market right now.
Round details
| Company | Lucis |
| Stage | series a |
| Amount | $20M |
| Announced | 26 May 2026 |
| Lead | Singular |
| Participation | General Catalyst, Y Combinator |
| Source | announcement ↗ |
Frequently asked questions
- How much did Lucis raise?
- Lucis raised $20M in its series-a round, announced 2026-05-26.
- Who invested in Lucis's series-a round?
- The round was led by Singular, with participation from General Catalyst and Y Combinator.
- What does Lucis do?
- AI-driven preventive healthcare platform combining biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect health risks earlier.
Verified 26 May 2026 · Sources: public filings